正常均值法与实时外部质量保证结合能否替代室内质量控制?
该文探讨室内质量控制(IQC)与外部质量保证(EQA)两个独立过程的现状,认为近期两者对患者结局改善有限。作者提出将两者整合为单一方法:以正常均值(Average of Normals)模型为基础,辅以更频繁的EQA样本,可能减少实验室人员困惑并更快识别失控情况。
要点
- IQC与EQA是独立发展但相关的两个过程,样本频率、统计解释和即时性不同。
- 分析平台可靠性和自动化提升及试剂稳定性改善已降低系统与随机误差。
- 建议用正常均值模型联合更频繁EQA样本,整合IQC与EQA为单一方法。
核心结论
- 作者认为应重新思考IQC与EQA的角色,将两者统一为基于正常均值模型并辅以更频繁EQA样本的单一方法。
研究设计与样本
- 本文为观点/评论类文章,未报告系统检索范围或原始研究样本。
主要发现
- 作者认为近期IQC与EQA两个过程均未对患者结局带来多大改善。
- 分析平台可靠性与自动化提升及试剂稳定性改善降低了系统误差和随机误差,从而降低了减少IQC频率的风险。
临床怎么用
- 作者提出可考虑以正常均值模型联合更频繁EQA样本,替代传统分开的IQC与EQA流程。
- 该整合方法可能减少实验室人员困惑,并加快对失控情况的响应和识别。
局限性
- 本文为观点性文章,未提供原始研究数据或验证性结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Internal Quality Control and External Quality Assurance are separate but related processes that have developed independently in laboratory medicine over many years. They have different sample frequencies, statistical interpretations and immediacy. Both processes have evolved absorbing new understandings of the concept of laboratory error, sample material matrix and assay capability. However, we do not believe at the coalface that either process has led to much improvement in patient outcomes recently. It is the increasing reliability and automation of analytical platforms along with improved stability of reagents that has reduced systematic and random error, which in turn has minimised the risk of running less frequent IQC. We suggest that it is time to rethink the role of both these processes and unite them into a single approach using an Average of Normals model supported by more frequent External Quality Assurance samples. This new paradigm may lead to less confusion for laboratory staff and quicker responses to and identification of out of control situations.
引用
- Badrick T, Graham P. Can a combination of average of normals and "real time" External Quality Assurance replace Internal Quality Control? Clin Chem Lab Med. 2018. PMID: 28902614. doi:10.1515/cclm-2017-0115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。